Adma Biologics (ADMA) Free Cash Flow Growth (3y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 31.42% |
| 10 | Adma Biologics | 1.90 Bn | 1.81 Bn | 88.82 Mn | 72.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 72.19% |
| Sep 30, 2025 | 59.89% |
| Jun 30, 2025 | 46.06% |
| Mar 31, 2025 | 5.47% |
| Dec 31, 2024 | 48.55% |
| Sep 30, 2024 | 51.53% |
| Jun 30, 2024 | 47.15% |
| Mar 31, 2024 | 49.67% |
| Dec 31, 2023 | 34.95% |
| Sep 30, 2023 | 34.26% |
| Jun 30, 2023 | 35.18% |
| Mar 31, 2023 | 14.56% |
| Dec 31, 2022 | 19.39% |
| Sep 30, 2022 | 13.88% |
| Jun 30, 2022 | 2.81% |
| Mar 31, 2022 | -26.08% |
| Dec 31, 2021 | -23.72% |
| Sep 30, 2021 | -8.25% |
| Jun 30, 2021 | -33.60% |
| Mar 31, 2021 | -28.22% |
| Dec 31, 2020 | -32.58% |
| Sep 30, 2020 | -37.39% |
| Jun 30, 2020 | -42.11% |
| Mar 31, 2020 | -70.39% |
| Dec 31, 2019 | -80.32% |
| Sep 30, 2019 | -77.21% |
| Jun 30, 2019 | -55.65% |
| Mar 31, 2019 | -40.55% |
| Mar 31, 2016 | -18.19% |